Pelago Bioscience Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 1

Pelago Bioscience General Information

Description

Provider of target engagement assay services intended to validate drug-target interactions in live cells. The company offers cellular thermal shift assay technology and profiling services, providing pharmaceutical companies with direct evidence of protein behavior in native environments to facilitate drug discovery.

Contact Information

Website
www.pelagobio.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Scheeles väg 1
  • 171 65 Stockholm
  • Sweden
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • Scheeles väg 1
  • 171 65 Stockholm
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pelago Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pelago Bioscience‘s full profile, request access.

Request a free trial

Pelago Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of target engagement assay services intended to validate drug-target interactions in live cells. The company of
Discovery Tools (Healthcare)
Stockholm, Sweden
50 As of 2026

Abingdon, United Kingdom
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pelago Bioscience Competitors (39)

One of Pelago Bioscience’s 39 competitors is Arctoris, a Venture Capital-Backed company based in Abingdon, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arctoris Venture Capital-Backed Abingdon, United Kingdom
Valo Venture Capital-Backed Lexington, MA
Chemical Computing Group Private Equity-Backed Montreal, Canada
NuMedii Formerly VC-backed San Mateo, CA
Zephyr AI Venture Capital-Backed McLean, VA
You’re viewing 5 of 39 competitors. Get the full list »

Pelago Bioscience Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • Pending

  • Expiring in next 12 mo

Pelago Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3123175-A1 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay Active 25-Mar-2014
EP-3123175-B1 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay Active 25-Mar-2014
GB-201405327-D0 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay Active 25-Mar-2014
GB-2524519-A Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay Active 25-Mar-2014
US-11480578-B2 Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay Active 25-Mar-2014 G01N33/6803
To view Pelago Bioscience’s complete patent history, request access »

Pelago Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pelago Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pelago Bioscience‘s full profile, request access.

Request a free trial

Pelago Bioscience Investments (1)

Pelago Bioscience’s most recent deal was a Buyout/LBO with RG Discovery. The deal was made on 15-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RG Discovery 15-Jun-2026 Buyout/LBO Drug Discovery
To view Pelago Bioscience’s complete investments history, request access »

Pelago Bioscience Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
RG Discovery Lund, Sweden 2011

Pelago Bioscience FAQs

  • When was Pelago Bioscience founded?

    Pelago Bioscience was founded in 2013.

  • Where is Pelago Bioscience headquartered?

    Pelago Bioscience is headquartered in Stockholm, Sweden.

  • What is the size of Pelago Bioscience?

    Pelago Bioscience has 50 total employees.

  • What industry is Pelago Bioscience in?

    Pelago Bioscience’s primary industry is Discovery Tools (Healthcare).

  • Is Pelago Bioscience a private or public company?

    Pelago Bioscience is a Private company.

  • What is Pelago Bioscience’s current revenue?

    The current revenue for Pelago Bioscience is .

  • Who are Pelago Bioscience’s investors?

    Impilo has invested in Pelago Bioscience.

  • Who are Pelago Bioscience’s competitors?

    Arctoris, Valo, Chemical Computing Group, NuMedii, and Zephyr AI are some of the 39 competitors of Pelago Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process